Teva, Pfizer Both Score Wins In Detrol Patent Fight

Law360, New York (December 10, 2008, 12:00 AM EST) -- Pfizer Inc. and Teva Pharmaceuticals Industries Ltd. have each notched victories in a patent suit over Pfizer's prescription bladder control drug Detrol.

Pfizer sued Teva subsidiary Ivax Pharmaceuticals Inc. in 2007, claiming that Ivax infringed the patent for Detrol by filing an abbreviated new drug application for a generic version of the drug. On Tuesday, Judge Dennis M. Cavanaugh of U.S. District Court for the District of New Jersey handed down four rulings on motions for summary judgment filed by both sides.

The judge granted Pfizer's...
To view the full article, register now.